A novel yeast-based high-throughput method for the identification of protein palmitoylation inhibitors

C Coronel Arrechea, ML Giolito, IA García… - Open …, 2021 - royalsocietypublishing.org
Protein S-acylation or palmitoylation is a widespread post-translational modification that
consists of the addition of a lipid molecule to cysteine residues of proteins through a …

[HTML][HTML] All good things must end: termination of receptor tyrosine kinase signal

A Margiotta - International journal of molecular sciences, 2021 - mdpi.com
Receptor tyrosine kinases (RTKs) are membrane receptors that regulate many fundamental
cellular processes. A tight regulation of RTK signaling is fundamental for development and …

Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer

PK Aktas, I Baysal, S Yabanoglu-Ciftci… - International Journal of …, 2023 - Elsevier
Lung cancer ranks as the second most commonly diagnosed cancer in both men and
women worldwide. Despite the availability of diverse diagnostic and treatment strategies, it …

Novel small molecule inhibitors targeting renal cell carcinoma: Status, challenges, future directions

L Xiong, Y Zhang, J Wang, M Yu, L Huang… - European Journal of …, 2024 - Elsevier
Renal cell carcinoma (RCC) is the most common renal malignancy with a rapidly increasing
morbidity and mortality rate gradually. RCC has a high mortality rate and an extremely poor …

[HTML][HTML] The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study

B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - Metabolites, 2021 - mdpi.com
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …

Rapid determination of the pharmacokinetics and metabolic fate of gefitinib in the mouse using a combination of UPLC/MS/MS, UPLC/QToF/MS, and ion mobility (IM) …

BJ Molloy, A King, LG Mullin, LA Gethings, R Riley… - Xenobiotica, 2021 - Taylor & Francis
The metabolism and pharmacokinetics of gefitinib (Iressa®, N-(3-chloro-4-fluorophenyl)-7-
methoxy-6-(3-morpholino-propoxy) quinazolin-4-amine), a selective thymidylate kinase …

[HTML][HTML] Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

A del Campo-Balguerías, B Parra-Cadenas… - International Journal of …, 2023 - mdpi.com
The modular synthesis of the guanidine core by guanylation reactions using commercially
available ZnEt2 as a catalyst has been exploited as a tool for the rapid development of …

[HTML][HTML] Targeted therapy recommendations for therapy refractory solid tumors—data from the real-world precision medicine platform MONDTI

H Taghizadeh, M Unseld, M Spalt, RM Mader… - Journal of personalized …, 2020 - mdpi.com
Advanced therapy-refractory solid tumors bear a dismal prognosis and constitute a major
challenge in offering effective treatment strategies. In this real-world retrospective analysis of …

Formulation and optimization of gefitinib-loaded nanosuspension prepared using a newly developed dendritic lipopeptide oligomer material

N Hegde, K Juvale, B Prabhakar - Chemical Papers, 2021 - Springer
Amino acid derived polypeptides are often biocompatible, and hence the materials of choice
in nanoparticle formulations to avoid nanotoxicity and associated complications. A …

A bioinformatic algorithm for analyzing cell signaling using temporal proteomic data

C Zhang, Y Chen, X Mao, Y Huang, SY Jung… - …, 2017 - Wiley Online Library
Significance analysis of proteomic data generated by LC‐MS/MS is challenging owing to
great data variability originated from biological, operational, and instrumental variations …